Evidence map›Paper›PMID 12761492›Full record

ArticleOncogene2003

Differential regulation of SOCS genes in normal and transformed erythroid cells.

Mohinder K Sarna, Evan Ingley, Samantha J Busfield, Vanessa S Cull, Winald Lepere, David J McCarthy, Michael J Wright, Gene A Palmer, David Chappell, Melissa S Sayer and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Mohinder K SarnaLaboratory for Cancer Medicine, Western Australian Institute for Medical Research, Royal Perth Hospital and Centre for Medical Research, The University of Western Australia, Perth, Australia.
Evan Ingley
Samantha J Busfield
Vanessa S Cull
Winald Lepere
David J McCarthy
Michael J Wright
Gene A Palmer
David Chappell
Melissa S Sayer
Warren S Alexander
Douglas J Hilton
Robyn Starr
Stephanie S Watowich
Thomas Bittorf
S Peter Klinken
Peta A Tilbrook
Royal Perth Hospital · AUHarry Perkins Institute of Medical Research · AUUniversity of Western Australia · AUWalter and Eliza Hall Institute of Medical Research · AUThe Royal Melbourne Hospital · AUThe University of Texas MD Anderson Cancer Center · USUniversity of Rostock · DE

Funding

Differentiation of Granulocytes and MacrophagesR37CA022556 · NCI · WALTER AND ELIZA HALL INST MEDICAL RES · PI METCALF, DONALD · 2005 to 2014
$2.3M
DIFFERENTIATION OF GRANULOCYTES AND MACROPHAGESR01CA022556 · NCI · WALTER AND ELIZA HALL INST MEDICAL RES · PI METCALF, DONALD · 1985 to 2004
$900k
MOLECULAR MECHANISMS CYTOKINE RECEPTOR SIGNALINGR01CA077447 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI WATOWICH, STEPHANIE S · 1998 to 2000
$250k
NCI NIH HHS CA-22556NCI NIH HHS CA-77447NCI NIH HHS R01 CA022556NCI NIH HHS R01 CA077447NCI NIH HHS R37 CA022556
6 · The paper itself

Abstract

The SOCS family of genes are negative regulators of cytokine signalling with SOCS-1 displaying tumor suppressor activity. SOCS-1, CIS and SOCS-3 have been implicated in the regulation of red blood cell production. In this study, a detailed examination was conducted on the expression patterns of these three SOCS family members in normal erythroid progenitors and a panel of erythroleukemic cell lines. Unexpectedly, differences in SOCS gene expression were observed during maturation of normal red cell progenitors, viz changes to CIS were inversely related to the alterations of SOCS-1 and SOCS-3. Similarly, these SOCS genes were differentially expressed in transformed erythoid cells - erythroleukemic cells immortalized at an immature stage of differentiation expressed SOCS-1 and SOCS-3 mRNA constitutively, whereas in more mature cell lines SOCS-1 and CIS were induced only after exposure to erythropoietin (Epo). Significantly, when ectopic expression of the tyrosine kinase Lyn was used to promote differentiation of immature cell lines, constitutive expression of SOCS-1 and SOCS-3 was completely suppressed. Modulation of intracellular signalling via mutated Epo receptors in mature erythroleukemic lines also highlighted different responses by the three SOCS family members. Close scrutiny of SOCS-1 revealed that, despite large increases in mRNA levels, the activity of the promoter did not alter after erythropoietin stimulation; in addition, erythroid cells from SOCS-1-/- mice displayed increased sensitivity to Epo. These observations indicate complex, stage-specific regulation of SOCS genes during normal erythroid maturation and in erythroleukemic cells.

Indexed as

Repressor ProteinsTranscription FactorsAnimalsCarrier ProteinsCell DifferentiationCell Line, TransformedCells, CulturedErythroid Precursor CellsErythropoietinGene Expression RegulationImmediate-Early ProteinsMiceMutationPromoter Regions, GeneticProtein BiosynthesisProteinsCarrier ProteinsErythropoietinImmediate-Early Proteinslyn protein-tyrosine kinaseProteinsReceptors, ErythropoietinRepressor ProteinsRNA, MessengerSocs1 protein, mouseSocs3 protein, mousesrc-Family KinasesSuppressor of Cytokine Signaling 1 ProteinSuppressor of Cytokine Signaling 3 ProteinSuppressor of Cytokine Signaling ProteinsTranscription Factors

Identifiers

PMID12761492
PMCPMC2396148
OpenAlexW2129823340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.